{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:48:15Z","timestamp":1794293295557,"version":"4.9.0"},"reference-count":22,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including global specialized laboratories, regional reference laboratories, national laboratories, and, in some countries, subnational laboratories. Regional networks are supervised by regional laboratory coordinators reporting to a global coordinator at WHO headquarters. Laboratories in the GMRLN have strong links to national disease control and vaccination programs. The GMRLN\u2019s goal is to support member states in obtaining timely, complete, and reliable laboratory-based surveillance data for measles and rubella as part of the strategy for achieving measles and rubella elimination. Surveillance data are reported to the national program and are included in annual reports on the status of measles and rubella elimination to national verification committees for review by regional verification commissions. Quality within the GMRLN is ensured by monitoring performance through external quality assurance programs, confirmatory and quality control testing, accreditation, and coordination of corrective action and training where needed. The overall performance of the laboratories has remained high over the years despite many challenges, particularly the COVID-19 pandemic. The GMRLN is well-positioned to support high-quality laboratory-based surveillance for measles and rubella and to transition to supporting laboratory testing for other pathogens, including vaccine-preventable diseases.<\/jats:p>","DOI":"10.3390\/vaccines12080946","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:53:37Z","timestamp":1724658817000},"page":"946","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance"],"prefix":"10.3390","volume":"12","author":[{"given":"Paul A.","family":"Rota","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Evans","sequence":"additional","affiliation":[{"name":"World Health Organization Western Pacific Regional Office, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam Corinne","family":"Ben Mamou","sequence":"additional","affiliation":[{"name":"World Health Organization European Regional Office, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5368-1740","authenticated-orcid":false,"given":"Gloria","family":"Rey-Benito","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, DC 20037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2553-4768","authenticated-orcid":false,"given":"Lucky","family":"Sangal","sequence":"additional","affiliation":[{"name":"World Health Organization Southeast Asia Regional Office, Delhi 110002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Dosseh","sequence":"additional","affiliation":[{"name":"World Health Organization African Regional Office, Brazzaville P.O. Box 06, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Ghoniem","sequence":"additional","affiliation":[{"name":"World Health Organization Eastern Mediterranean Regional Office, Cairo 11371, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Byabamazima","sequence":"additional","affiliation":[{"name":"World Health Organization African Regional Office, Brazzaville P.O. Box 06, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-0874","authenticated-orcid":false,"given":"Maurice","family":"Demanou","sequence":"additional","affiliation":[{"name":"World Health Organization African Regional Office, Brazzaville P.O. Box 06, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1334-3462","authenticated-orcid":false,"given":"Raydel","family":"Anderson","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gimin","family":"Kim","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Bankamp","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Suzanne","family":"Beard","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5767","authenticated-orcid":false,"given":"Stephen N.","family":"Crooke","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-5003","authenticated-orcid":false,"given":"Sumathi","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1933-0726","authenticated-orcid":false,"given":"Ana","family":"Penedos","sequence":"additional","affiliation":[{"name":"United Kingdom Health Security Agency, London NW9 5EQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Stambos","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-7150","authenticated-orcid":false,"given":"Suellen","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Featherstone","sequence":"additional","affiliation":[{"name":"Consultant Scientists Ltd., Hastings 4122, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-2690","authenticated-orcid":false,"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[{"name":"World Health Organization, 1211 Gen\u00e8ve, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcv.2003.11.006","article-title":"Evaluation of rubella IgM enzyme immunoassays","volume":"30","author":"Tipples","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_2","unstructured":"World Health Organization (1998). Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Relev. Epidemiol. Hebd., 73, 265\u2013269."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15585\/mmwr.mm6517a3","article-title":"Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010\u20132015","volume":"65","author":"Mulders","year":"2016","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_4","unstructured":"(2024, July 11). MeaNS and RubeNS. Available online: https:\/\/who-gmrln.org\/."},{"key":"ref_5","unstructured":"Association of Public Health Laboratories (2024, July 12). Vaccine Preventable Diseases. Available online: https:\/\/www.aphl.org\/programs\/infectious_disease\/Pages\/VPD.aspx."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/JCM.01879-16","article-title":"Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR","volume":"55","author":"Roy","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00268-16","article-title":"High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases","volume":"23","author":"Sowers","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Coughlin, M.M., Matson, Z., Sowers, S.B., Priest, J.W., Smits, G.P., van der Klis, F.R.M., Mitchell, A., Hickman, C.J., Scobie, H.M., and Goodson, J.L. (2021). Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity. J. Clin. Microbiol., 59.","DOI":"10.1128\/JCM.02716-20"},{"key":"ref_9","unstructured":"World Health Organization (2024, July 22). Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome. Available online: https:\/\/www.technet-21.org\/en\/manual-introduction."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coviro.2020.05.007","article-title":"Rapid diagnostic tests to address challenges for global measles surveillance","volume":"41","author":"Brown","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_11","unstructured":"(2024, July 22). Target Product Profile for Surveillance Tests for Measles and Rubella. Available online: https:\/\/www.finddx.org\/wp-content\/uploads\/2024\/06\/20240613_tpp_measles_rubell_FV_EN.pdf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.05537-11","article-title":"Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus","volume":"19","author":"Smits","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_13","first-page":"485","article-title":"Update: Circulation of active genotypes of measles virus and recommendations for use of sequence analysis to monitor viral transmission","volume":"97","author":"Williams","year":"2022","journal-title":"Relev. Epidemiol. Hebd."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bankamp, B., Kim, G., Hart, D., Beck, A., Rota, P.A., Zhang, Y., and Ben Mamou, M. (2024). Global update on measles molecular epidemiology. Vaccines, 12.","DOI":"10.3390\/vaccines12070810"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15585\/mmwr.mm7308a2","article-title":"Progress Toward Rubella and Congenital Rubella Syndrome Elimination\u2014Worldwide, 2012\u20132022","volume":"73","author":"Ou","year":"2024","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1099\/jgv.0.000680","article-title":"Genetic diversity of currently circulating rubella viruses: A need to define more precise viral groups","volume":"98","author":"Rivailler","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_17","unstructured":"World Health Organization (2024, July 22). Measles and Rubella Strategic Framework: 2021\u20132030. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/339801\/9789240015616-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_18","unstructured":"World Health Organization (2024, July 22). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Available online: https:\/\/www.who.int\/publications\/m\/item\/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1093\/infdis\/jix077","article-title":"Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms","volume":"216","author":"Mulders","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_20","unstructured":"World Health Organization (2018). Polio Transition and Post-Certification Draft Strategic Action Plan on Polio Transition, World Health Organization. Seventy-first World Health Assembly, A71\/9 Provisional Agenda Item."},{"key":"ref_21","unstructured":"World Health Organization (2024, July 22). Global Strategy for Comprehensive Vaccine-Preventable Disease (VPD) Surveillance. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/vpd_surveillance\/bls20116-ia-global-strategy-english.pdf?sfvrsn=748c3e30_4&download=true."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.vaccine.2022.07.024","article-title":"A global comprehensive vaccine-preventable disease surveillance strategy for the immunization Agenda 2030","volume":"42","author":"Patel","year":"2022","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/946\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:41:05Z","timestamp":1760110865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["vaccines12080946"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12080946","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}